A machine learning platform that predicts phenotypes from multi-omic data using ensemble methods. Built on the OutPredict system, it leverages random forest and Naive Bayes ensembles to identify causal, non-linear relati...
A crystal engineering approach that transforms commercial contact insecticides into metastable yet persistent polymorphic forms to accelerate insect knockdown, reduce active ingredient usage, and counter resistance. Vali...

Innovative hydroconversion process utilizing nickel-molybdenum sulfide catalyst to convert polyolefin-rich plastic waste into lubricant oil. Achieves 80-85% yield with minimal pre-cleaning and operates continuously in a ...

This technology offers an innovative catalytic process to convert polyolefin-rich plastic waste into high-value wax using NiMoS₂ catalysts, achieving 80-85% yields at lower temperatures than traditional methods. The proc...
Cross-population microbiome studies are limited by heterogeneous data, cross-sectional designs, and lack of integrated health and omics datasets. The Nepali Maternal and Infant Microbiome Study (NeMaSiMa) addresses these...
The Salivary Cytokine Index is a novel, noninvasive method developed by NYU researchers that uses a composite score of salivary cytokines to measure the severity of periodontal inflammation. By analyzing specific pro- an...
NYU's Clasping Antibody Platform generates high-affinity, recombinant antibodies that use a unique cooperative binding mode to target challenging antigens, such as site-specific post-translational modifications. This tec...
NYU offers a licensable research platform and gene therapy development strategy for arrhythmogenic right ventricular cardiomyopathy (ARVC/D). The solution includes a validated cardiomyocyte-specific PKP2 knockout mouse m...
A platform for identifying and modulating intrinsic neuronal resistance mechanisms to combat neurodegenerative diseases like ALS and FTD. By leveraging stem cell-derived neuron models, the technology targets RNA-binding ...
NYU researchers have identified the ELOVL1 enzyme as a critical regulator of neurotoxic reactive astrocytes that drive neuronal and oligodendrocyte death in various CNS diseases. By inhibiting ELOVL1, this therapeutic ap...